Industry Developments

The European market for oral contraceptives and arbortificants could be affected by moves in both Ireland and Italy to relax laws governing these products. However, as both countries... 2008-02-28

A ruling by the Barcelona High Court upholding the patent for US-based drugmaker Eli Lilly 's schizophrenia drug Zyprexa (olanzapine) could have far-reaching implications for the... 2008-02-27

The Italian medical devices market was worth approximately US$6.0bn in 2007 and should reach a value of US$7.3bn in 2012. This represents a compound average growth rate of about 4%,... 2008-02-26

UK-based drugmaker Shire has announced positive results for 2007, driven by good performances form its leading products and the emergence of Vyvanse (lisdexamfetamine dimesylate),... 2008-02-25

A team of British scientists has been sent to India in order to promote the UK as a destination for hi-tech research in areas such as stem-cell technology and biotech. This is an... 2008-02-22

According to a new study by the German Association of Research-Based Pharmaceutical Companies (VFA), the under-treatment of patients is costing Germany millions of euros each year.... 2008-02-21

In a critique of the UK's National Health Service (NHS), thinktank

Belgium's efforts to keep drug spending down look as if they are being rewarded, with sales of reimbursed drugs increasing by less than 7% in 2007, within the national health insurance... 2008-02-19

Germany's drug discount contracts have come under fire from the German Association of Medicines Manufacturers (BAH), which claims that they are anti-competitive and will hurt small... 2008-02-14

Following rapid growth earlier in the decade, the Spanish medical devices reached an estimated value of US$3.9bn in 2007. Although the market is still expanding at a brisk pace in... 2008-02-13